Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Nurse Staff

Advertisement

Articles by Nurse Staff

Let's Talk Managing Symptoms and Side Effects With Darcy Burbage

ByNurse Staff
June 29th 2016

Cancer survivors often experience physical and psychosocial long-term and late effects after treatment ends.

Advertisement

Latest Updated Articles

  • Let's Talk Managing Symptoms and Side Effects With Darcy Burbage
    Let's Talk Managing Symptoms and Side Effects With Darcy Burbage

    June 29th 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications

2

FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients

3

Frontline Sevabertinib Approved in HER2-Mutant NSCLC: Nursing Priorities

4

FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care

5

Personalizing Frontline ADC Selection in Metastatic Triple-Negative Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us